Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death^†

References

• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
   PubMed Web of Science ®Google Scholar
• von Ardenne M, Kruger W. Combined whole-body and local hyperthermia for cancer treatment: CMT selectotherm technique. Prog Clin Biol Res 1982; 107: 705–713
   PubMedGoogle Scholar
• Overgaard J, Bichel P. The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro. Radiology 1977; 123: 511–514
   PubMed Web of Science ®Google Scholar
• Kang MS, Song CW, Levitt SH. Role of vascular function in response of tumors in vivo to hyperthermia. Cancer Res 1980; 40: 1130–1135
   PubMed Web of Science ®Google Scholar
• Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park HJ, Song CW, Kano E, Saito H. Acidic environment modifies heat- or radiation-induced apoptosis in human maxillary cancer cells. Int J Radiat Oncol Biol Phys 2001; 49: 1391–1398
   PubMed Web of Science ®Google Scholar
• Sawaji Y, Sato T, Takeuchi A, Hirata M, Ito A. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer 2002; 86: 1597–1603
   PubMed Web of Science ®Google Scholar
• Murata T, Akagi K, Imamura M, Nasu R, Kimura H, Nagata K, Tanaka K. Studies on hyperthermia combined with arterial therapeutic blockade for treatment of tumors: (Part III) Effectiveness of hyperthermia combined with arterial chemoembolization using degradable starch microspheres on advanced liver cancer. Oncol Rep 1998; 5: 709–712
   PubMed Web of Science ®Google Scholar
• Ben-Yosef R, Vigler N, Inbar M, Vexler A. Hyperthermia combined with radiation therapy in the treatment of local recurrent breast cancer. Isr Med Assoc 2004; J6: 392–395
   Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
   PubMed Web of Science ®Google Scholar
• Hegewisch-Becker S, Hossfeld DK. [Addition of hyperthermia. Heat potentiates cancer therapy]. MMW Fortschr Med 2001; 143: 28–32
   PubMedGoogle Scholar
• Roberts NJ, Jr. Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991; 13: 462–472
   PubMedGoogle Scholar
• Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181: 67–73
   PubMed Web of Science ®Google Scholar
• Mageed AS, Pietryga DW, DeHeer DH, West RA. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: Characterization of fresh mesenchymal stem cells. Transplantation 2007; 83: 1019–1026
   PubMed Web of Science ®Google Scholar
• Anokhina EB, Burakova LB. [Heterogeneity of stromal precursor cells isolated from rat bone marrow]. Tsitologiia 2007; 49: 40–47
   PubMedGoogle Scholar
• Fierro FA, Sierralta WD, Epunan MJ, Minguell JJ. Marrow-derived mesenchymal stem cells: Role in epithelial tumor cell determination. Clin Exp Metastasis 2004; 21: 313–319
   PubMed Web of Science ®Google Scholar
• Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BM, Champlin RE, Andreeff M. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593–1603
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557–563
   PubMed Web of Science ®Google Scholar
• Hung SC, Deng WP, Yang WK, Liu RS, Lee CC, Su TC, Lin RJ, Yang DM, Chang CW, Chen WH, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005; 11: 7749–7756
   PubMed Web of Science ®Google Scholar
• Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC, et al. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 2006; 199: 301–310
   PubMed Web of Science ®Google Scholar
• Detmar M, Velasco P, Richard L, Claffey KP, Streit M, Riccardi L, Skobe M, Brown LF. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol 2000; 156: 159–167
   PubMed Web of Science ®Google Scholar
• Alberti C. Prostate cancer progression and surrounding microenvironment. Int J Biol Markers 2006; 21: 88–95
   PubMed Web of Science ®Google Scholar
• Kopfstein L, Christofori G. Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006; 63: 449–668
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822
   PubMed Web of Science ®Google Scholar
• Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, Cao W, Han C, Chen Y. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80: 267–274
   PubMed Web of Science ®Google Scholar
• Hombauer H, Minguell JJ. Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 2000; 82: 1290–1296
   PubMed Web of Science ®Google Scholar
• Hall B, Andreeff M, Marini F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007; 180: 263–283
   Google Scholar
• Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 2005; 54: 721–728
   PubMed Web of Science ®Google Scholar
• Marsters SA, Pitti RA, Sheridan JP, Ashkenazi A. Control of apoptosis signaling by Apo2 ligand. Recent Prog Horm Res 1999; 54: 225–234
   PubMedGoogle Scholar
• Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, et al. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol Pharmacol 2007; 72: 152–161
   PubMedGoogle Scholar
• Jiang EZ, Chang YJ, Lee JW, Lee WK, Kim JS, Sohn SK, Lee KB, Suh JS. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: Correlations with CD surface markers and treatment outcome. J Korean Med Sci 1998; 13: 617–622
   PubMedGoogle Scholar
• Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN. A death-domain-containing receptor that mediates apoptosis. Nature 1996; 384: 372–375
   PubMed Web of Science ®Google Scholar
• Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007; 25: 520–528
   PubMed Web of Science ®Google Scholar
• Rowley DR. What might a stromal response mean to prostate cancer progression?. Cancer Metastasis Rev 1998; 17: 411–419
   PubMed Web of Science ®Google Scholar
• Baronzio G, Gramaglia A, Fiorentini G. Hyperthermia and immunity. A brief overview. In vivo 2006; 20: 689–695
   PubMed Web of Science ®Google Scholar
• Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 2003; 17: 615–628
   PubMed Web of Science ®Google Scholar
• Salti GI, Grewal S, Mehta RR, Das Gupta TK, Boddie AW, Jr, Constantinou AI. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer 2000; 36: 796–802
   PubMed Web of Science ®Google Scholar
• Hille S, Rein DT, Riffelmann M, Neumann R, Sartorius J, Pfutzner A, Kurbacher CM, Schondorf T, Breidenbach M. Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer. Anticancer Drugs| 2006; 17: 1041–1044
   PubMed Web of Science ®Google Scholar
• Vincent T, Mechti N. Extracellular matrix in bone marrow can mediate drug resistance in myeloma. Leuk Lymphoma 2005; 46: 803–811
   PubMed Web of Science ®Google Scholar
• Bubenik J. Tumour MHC class I downregulation and immunotherapy (Review). Oncol Rep 2003; 10: 2005–2008
   PubMed Web of Science ®Google Scholar
• Marten A, Ziske C, Schottker B, Weineck S, Renoth S, Buttgereit P, Schakowski F, Konig S, von Rucker A, Allera A, et al. Transfection of dendritic cells (DCs) with the CIITA gene: Increase in immunostimulatory activity of DCs. Cancer Gene Ther 2001; 8: 211–219
   PubMed Web of Science ®Google Scholar
• Chaperot L, Jacob MC, Molens JP, Manches O, Bensa JC, Plumas J. From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas. Leuk Lymphoma 2000; 38: 247–263
   PubMed Web of Science ®Google Scholar
• Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, Kornfeld H, Center DM, Metcalfe DD. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997; 159: 2904–2910
   PubMed Web of Science ®Google Scholar
• Song HL, Lu S, Liu P. [Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure.]. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 290–293
   PubMedGoogle Scholar